~~<i id='A54091EC0B'><strike id='A54091EC0B'><tt id='A54091EC0B'><pre id='A54091EC0B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：comprehensive 2025-09-28 00:51:31 - browse：88225

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

However, some outside experts expressed skepticism about the result.

Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin — is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Health insurers' Q3 question: how much care are people getting?

hotspot

focus

entertainment

leisure time

HealthsecretaryXavierBecerrareceivesanupdatedCovid-19boosterinSeptember.DrewAngerer/GettyImagesWASHI

WSS

The stability of $0 premiums in Medicare Advantage

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Virtual Event: March of the Biosimilars

IVG is promising — but it won’t replace IVF quite yet

Neuroscience’s long legacy of racism

New oral drug delivery patch is modeled after octopus tentacles

focus

explore

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Future doctors should be trained to promote social change

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

European officials brace for rough respiratory virus season

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Activists slam private health insurers over coverage restrictions

AstraZeneca to buy developer of next

The high cost of giving birth even with insurance

What we owe ALS patients — and why one company fell short

hotspot

Asbestos, a deadly carcinogen, banned by EPA

The stability of $0 premiums in Medicare Advantage

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

The United States is paying nearly triple for new Covid vaccines

Medicare innovation center doesn’t save money, experts say

With Roe v Wade overturned, abortion providers work to adapt

hotspot

focus

entertainment

leisure time